• Drlogy Plus
Home/Medical Dictionary/MOAB Ch14.18

MOAB Ch14.18

A drug used with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (IL-2), and 13-cis-retinoic acid to treat children with high-risk neuroblastoma. It is used in patients whose disease has gotten better with other anticancer treatment. MOAB Ch14.18 binds to a substance called GD2, which is found on some types of cancer cells. MOAB Ch14.18 may block GD2 and help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called Ch14.18, dinutuximab, monoclonal antibody Ch14.18, and Unituxin.

Explore Medical Terms

20000+ Medical & Health Terms for Doctors, students & patients from a medical dictionary. Our experts define difficult medical & health language in easy-to-understand explanations of each and every medical term.

Medical & Health Terms online medical dictionary provides quick & easy access to hard-to-spell and often misspelled medical & health definitions through an extensive alphabetical A-Z listing.

DOCTOR'S MOST TRUSTED HEALTHCARE PLATFORM

10M+Patients

30000+Doctors

25000+Hospitals/Labs

Dictionary

Abbreviation

App

Health

Plus